The role of toxin A and toxin B in Clostridium difficile-associated disease: Past and present perspectives
- PMID: 20664812
- PMCID: PMC2906822
- DOI: 10.4161/gmic.1.1.10768
The role of toxin A and toxin B in Clostridium difficile-associated disease: Past and present perspectives
Abstract
Recently, we constructed and characterized isogenic tcdA and tcdB mutants of a virulent Clostridium difficile strain and used a hamster model of disease to demonstrate that toxin B, not toxin A, is essential for virulence of this emerging pathogen. Earlier studies had shown that purified toxin A alone was able to induce C. difficile disease pathology and that purified toxin B was not effective unless it was co-administered with toxin A, suggesting that the toxins act synergistically. In this addendum we discuss this paradigm-shifting conclusion in the context of current strain epidemiology, particularly with respect to naturally occurring toxin A-negative, toxin B-positive isolates and the NAP1/027 epidemic isolates. The role of toxin receptors and how variant toxins might exert their effects is also discussed in relation to the published data. We conclude that it is critical to use the natural infection process to dissect the role of toxins in disease, and that future studies are contingent on such work. The impact and importance of animal models of C. difficile virulence are therefore considered within this frame of reference.
Figures




Comment on
-
Toxin B is essential for virulence of Clostridium difficile.Nature. 2009 Apr 30;458(7242):1176-9. doi: 10.1038/nature07822. Epub 2009 Mar 1. Nature. 2009. PMID: 19252482 Free PMC article.
Similar articles
-
Toxin B is essential for virulence of Clostridium difficile.Nature. 2009 Apr 30;458(7242):1176-9. doi: 10.1038/nature07822. Epub 2009 Mar 1. Nature. 2009. PMID: 19252482 Free PMC article.
-
Defining the Roles of TcdA and TcdB in Localized Gastrointestinal Disease, Systemic Organ Damage, and the Host Response during Clostridium difficile Infections.mBio. 2015 Jun 2;6(3):e00551. doi: 10.1128/mBio.00551-15. mBio. 2015. PMID: 26037121 Free PMC article.
-
Clostridium difficile chimeric toxin receptor binding domain vaccine induced protection against different strains in active and passive challenge models.Vaccine. 2017 Jul 24;35(33):4079-4087. doi: 10.1016/j.vaccine.2017.06.062. Epub 2017 Jun 29. Vaccine. 2017. PMID: 28669616
-
The enterotoxicity of Clostridium difficile toxins.Toxins (Basel). 2010 Jul;2(7):1848-80. doi: 10.3390/toxins2071848. Epub 2010 Jul 14. Toxins (Basel). 2010. PMID: 22069662 Free PMC article. Review.
-
Clostridium difficile virulence factors: Insights into an anaerobic spore-forming pathogen.Gut Microbes. 2014;5(5):579-93. doi: 10.4161/19490976.2014.969632. Gut Microbes. 2014. PMID: 25483328 Free PMC article. Review.
Cited by
-
Clostridioides (Clostridium) Difficile in Food-Producing Animals, Horses and Household Pets: A Comprehensive Review.Microorganisms. 2019 Dec 9;7(12):667. doi: 10.3390/microorganisms7120667. Microorganisms. 2019. PMID: 31835413 Free PMC article. Review.
-
Systemically administered IgG anti-toxin antibodies protect the colonic mucosa during infection with Clostridium difficile in the piglet model.PLoS One. 2014 Oct 27;9(10):e111075. doi: 10.1371/journal.pone.0111075. eCollection 2014. PLoS One. 2014. PMID: 25347821 Free PMC article.
-
Spironolactone and colitis: increased mortality in rodents and in humans.Inflamm Bowel Dis. 2012 Jul;18(7):1315-24. doi: 10.1002/ibd.21929. Epub 2011 Nov 13. Inflamm Bowel Dis. 2012. PMID: 22081497 Free PMC article.
-
Chemical Genomics, Structure Elucidation, and in Vivo Studies of the Marine-Derived Anticlostridial Ecteinamycin.ACS Chem Biol. 2017 Sep 15;12(9):2287-2295. doi: 10.1021/acschembio.7b00388. Epub 2017 Jul 26. ACS Chem Biol. 2017. PMID: 28708379 Free PMC article.
-
Microbiota-mediated protection against antibiotic-resistant pathogens.Genes Immun. 2021 Oct;22(5-6):255-267. doi: 10.1038/s41435-021-00129-5. Epub 2021 May 4. Genes Immun. 2021. PMID: 33947987 Free PMC article. Review.
References
-
- McDonald LC, Killgore GE, Thompson A, Owens RC, Kazakova SV, Sambol SP, et al. An epidemic, toxin gene-variant strain of Clostridium difficile. NEJM. 2005;353:2433–2441. - PubMed
-
- Warny M, Pepin J, Fang A, Killgore G, Thompson A, Brazier J, et al. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet. 2005;366:1079–1084. - PubMed
-
- Bartlett JG, Moon N, Chang TW, Taylor N, Onderdonk AB. Role of Clostridium difficile in antibiotic-associated pseudomembranous colitis. Gastroenterology. 1978;75:778–782. - PubMed
-
- Bartlett JG. Antibiotic-associated diarrhea. The New England Journal of Medicine. 2002;346:334–339. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous